Shopping Cart
0 Item in Cart

Generic Drug Product Development International Regulatory Requirements for Bioequivalance (HB)
Click for related books: Kanfer

Rating  
(80 Ratings)

Retail Price: 3995.00/-
Price: 3596.00/-
Inclusive all taxes
10.00% OFF
Sold By: Store4Doctors

Offer 1: Get 10.00% + Flat ₹ 50 discount on shopping of ₹ 1500
                use code:
MPSTK50

Offer 2: Get 10.00% + Flat ₹ 150 discount on shopping of
                ₹ 5000 use code:
MPSTK150

Free Shipping (for orders above ₹ 499)  *T&C apply.

In Stock Click For New Edition
Select Quantity :



Description

Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country.? This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.

More Details About Generic Drug Product Development International Regulatory Requirements for Bioequivalance (HB)
General Information
Author(s)Kanfer
PublisherInforma Healthcare
ISBN9780849377853
Pages309
BindingHard Back
LanguageEnglish
Publish YearJanuary 2010
Reviews of Generic Drug Product Development International Regulatory Requirements for Bioequivalance (HB)
Average Rating

Write A Review

TOP REVIEWS


Top Reviews lists the most relevant product reviews only.


RECENT TOP REVIEWS